Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Müllinger B[au]:

Search results

Items: 34

1.

Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study.

Arnitz R, Stein M, Bauer P, Lanthaler B, Jamnig H, Scholl-Bürgi S, Stempfl-Al-Jazrawi K, Ulmer H, Baumgartner B, Embacher S, Geisler S, Gostner JM, Müllinger B, Kälz B, Nagl M.

Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618778955. doi: 10.1177/1753466618778955.

2.

The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension.

Gessler T, Ghofrani HA, Held M, Klose H, Leuchte H, Olschewski H, Rosenkranz S, Fels L, Li N, Ren D, Kaiser A, Schultze-Mosgau MH, Müllinger B, Rohde B, Seeger W.

Pulm Circ. 2017 Apr-Jun;7(2):505-513. doi: 10.1177/2045893217706691. Epub 2017 May 12.

3.

Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.

Bakker EM, Volpi S, Salonini E, Müllinger B, Kroneberg P, Bakker M, Hop WC, Assael BM, Tiddens HA.

Pediatr Pulmonol. 2014 Feb;49(2):154-61. doi: 10.1002/ppul.22800. Epub 2013 Jul 3.

PMID:
23913868
4.

Small-airways deposition of dornase alfa in children with asthma and persistent airway obstruction.

Bakker EM, van der Wiel-Kooij EC, Müllinger B, Kroneberg P, Hop WC, Tiddens HA.

J Allergy Clin Immunol. 2013 Aug;132(2):482-5.e10. doi: 10.1016/j.jaci.2013.02.006. Epub 2013 Mar 28. No abstract available.

PMID:
23541323
5.

What puts the adverse in 'adverse events'? Patients' perceptions of post-treatment experiences in osteopathy--a qualitative study using focus groups.

Rajendran D, Bright P, Bettles S, Carnes D, Mullinger B.

Man Ther. 2012 Aug;17(4):305-11. doi: 10.1016/j.math.2012.02.011. Epub 2012 Mar 15.

PMID:
22425134
6.

Adverse events and manual therapy: a systematic review.

Carnes D, Mars TS, Mullinger B, Froud R, Underwood M.

Man Ther. 2010 Aug;15(4):355-63. doi: 10.1016/j.math.2009.12.006. Epub 2010 Jan 22. Review.

PMID:
20097115
7.

Reprint of: a preliminary assessment of the impact of cranial osteopathy for the relief of infantile colic.

Hayden C, Mullinger B.

Complement Ther Clin Pract. 2009 Nov;15(4):198-203. Epub 2009 Sep 9.

PMID:
19880081
8.

Defining adverse events in manual therapies: a modified Delphi consensus study.

Carnes D, Mullinger B, Underwood M.

Man Ther. 2010 Feb;15(1):2-6. doi: 10.1016/j.math.2009.02.003. Epub 2009 May 13.

PMID:
19443262
9.

Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.

Scheuch G, Brand P, Meyer T, Herpich C, Müllinger B, Brom J, Weidinger G, Kohlhäufl M, Häussinger K, Spannagl M, Schramm W, Siekmeier R.

J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):603-14.

10.

Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods.

Dopfer R, Brand P, Müllinger B, Hunger T, Häussermann S, Meyer T, Scheuch G, Siekmeier R.

J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 1):141-54.

11.

[Comparison of unspecific bronchial provocation during controlled and spontaneous inhalation].

Wenzel C, Brand P, Herpich C, Häussermann S, Meyer T, Müllinger B, Scheuch G, Häussinger K.

Pneumologie. 2006 Aug;60(8):467-71. German.

PMID:
16933188
12.

A preliminary assessment of the impact of cranial osteopathy for the relief of infantile colic.

Hayden C, Mullinger B.

Complement Ther Clin Pract. 2006 May;12(2):83-90. Epub 2006 Feb 8.

PMID:
16648084
13.

Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis.

Griese M, Ramakers J, Krasselt A, Starosta V, Van Koningsbruggen S, Fischer R, Ratjen F, Müllinger B, Huber RM, Maier K, Rietschel E, Scheuch G.

Am J Respir Crit Care Med. 2004 Apr 1;169(7):822-8. Epub 2004 Jan 15.

PMID:
14726422
14.

Pulmonary deposition of monodisperse aerosols in patients with chronic obstructive pulmonary disease.

Meyer T, Müllinger B, Sommerer K, Scheuch G, Brand P, Beckmann H, Häussinger K, Weber N, Siekmeier R.

Exp Lung Res. 2003 Oct-Nov;29(7):475-84.

PMID:
14710439
15.

Peripheral deposition of alpha1-protease inhibitor using commercial inhalation devices.

Brand P, Beckmann H, Maas Enriquez M, Meyer T, Müllinger B, Sommerer K, Weber N, Weuthen T, Scheuch G.

Eur Respir J. 2003 Aug;22(2):263-7.

16.

In vitro testing of two formoterol dry powder inhalers at different flow rates.

Weuthen T, Roeder S, Brand P, Müllinger B, Scheuch G.

J Aerosol Med. 2002 Fall;15(3):297-303.

PMID:
12396417
17.

Increased sputum IL-8 and IL-5 in asymptomatic nonspecific airway hyperresponsiveness.

Betz R, Kohlhäufl M, Kassner G, Müllinger B, Maier K, Brand P, Weber N, Häussinger K, Heyder J, Frankenberger M.

Lung. 2001;179(2):119-33.

PMID:
11733854
18.
19.

Acrivastine in allergic rhinitis: a review of clinical experience.

Bojkowski CJ, Gibbs TG, Hellstern KH, Major EW, Mullinger B.

J Int Med Res. 1989;17 Suppl 2:54B-68B. Review.

PMID:
2570003
20.

Ranitidine drug interactions--a literature review.

Mitchard M, Harris A, Mullinger BM.

Pharmacol Ther. 1987;32(3):293-325. Review. No abstract available.

PMID:
3310029
21.

Responses of human peripheral arteries to agonists: similarities and differences.

Wyse GD, McMartin G, Mullinger B.

Fed Proc. 1985 Feb;44(2):331-6.

PMID:
3967775
22.

Treatment of cytotoxic drug-related infections.

McVie JG, Stuart JF, Mullinger BM.

Clin Ther. 1983;5(4):385-90.

PMID:
6871921
23.

A new dry powder inhaler.

Pover GM, Browning AK, Mullinger BM, Butler AG, Dash CH.

Practitioner. 1982 Mar;226(1365):565-7. No abstract available.

PMID:
7088851
24.

Cefuroxime: potential use in pregnant women at term.

Bousfield P, Browning AK, Mullinger BM, Elstein M.

Br J Obstet Gynaecol. 1981 Feb;88(2):146-9.

PMID:
7459305
25.

Placental transfer of cefuroxime.

Craft I, Mullinger BM, Kennedy MR.

Br J Obstet Gynaecol. 1981 Feb;88(2):141-5.

PMID:
7459304
26.

Cefuroxime and ampicillin compared in a double-blind study in the treatment of lower respiratory tract infections.

Pines A, Raafat H, Khorasani M, Mullinger BM.

Chemotherapy. 1981;27(6):459-65.

PMID:
7028411
27.

Cefuroxime compared with penicillin for the treatment of gonorrhea.

Morrison GD, Evans AJ, Haskins HW, Lewis NM, Seale GH, Mayall E, Mullinger BM.

Sex Transm Dis. 1980 Oct-Dec;7(4):188-90.

PMID:
7006118
28.

Experience with cefuroxime in 190 patients with severe respiratory infections.

Pines A, Raafat H, Kennedy MR, Mullinger BM.

Chemotherapy. 1980;26(3):212-7.

PMID:
7363715
29.

Single-dose cefuroxime in the prophylaxis of abdominal wound sepsis.

Lambert WG, Mullinger BM.

Curr Med Res Opin. 1980;6(6):404-6.

PMID:
6988170
30.

Cefuroxime in the treatment of lower respiratory tract infection.

Bax RP, Dawson AF, Mullinger BM, Dash CH.

Curr Med Res Opin. 1979;5(10):772-8.

PMID:
373991
31.

Cephalexin in the prevention of recurrent cystitis.

Mullinger BM, Eilon LA.

Practitioner. 1978 Nov;221(1325):769-72. No abstract available.

PMID:
368752
32.

Neonatal vaccination with 'universal strength' BCG vaccine.

Heyworth B, Mullinger BM.

Arch Dis Child. 1977 Jun;52(6):503-4.

33.

A trial to investigate reactions and responses to BCG vaccines of different strengths prepared from the Copenhagen 1331 strain.

Brindle TW, Holme T, Stalker R, Muggleton PW, Mullinger BM.

Tubercle. 1975 Mar;56(1):37-44.

PMID:
1096389
34.

Cephalexin and oxytetracycline compared by double-blind trial in the treatment of bronchitis in general practice.

Mullinger BM, Foord RD.

Curr Med Res Opin. 1974;2(6):356-65. No abstract available.

PMID:
4614947

Supplemental Content

Loading ...
Support Center